Third, JQ1 mainly targets BRD4, but the targets protein related to SE include BRD2, BRD3, or BRDT etc. In the future, the search for dual-target inhibitors based on the BRD4-related pathways is expected to reduce off-target and improve the efficacy of tumor therapy. This evidence concerns the gene BRD3 and neoplasm.